The following information is about Lipoproteins.

Lipoproteins Defined

Are you looking for additional Health > Lipoproteins news? Try our new "Lipoproteins News Focus" area.

Off-site Lipoproteins Links, User Submitted

The following links have been collected through user bookmark submission in the Lipoproteins category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Wed Aug 20

• Effect of lipoprotein (a) on platelet activation induced by platelet-activ ating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydr olase -- Tsironis et al. 63 (1): 130 -- Cardiovascular Research: Lipoprotein (a) [Lp(a)] is considered an atherogenic lipoprotein, which is also implicated in thrombosis. Lp(a) binds to platelets and modulates the effects of various platelet agonists. Platelet activating factor (PAF) is a potent platelet agonist degraded and inactivated by PAF-acetylhydr olase (PAF-AH), which in plasma is associated with lipoproteins.

Tue Aug 19

• Subendothelial lipoprotein retention as the initiating process in atherosclerosi s: update and therapeutic implications.: The key initiating process in atherogenesis is the subendothelial retention of apolipoprotein B-containing lipoproteins. Local biological responses to these retained lipoproteins, including a chronic and maladaptive macrophage- and T-cell-dominat ed inflamm?
• Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosi s.
• Plaque Stability and Plaque Regression: New Insights | European Heart Journal 2006

Fri Aug 15

• Mixed Dyslipidemia and Risk Reduction : Treatment Beyond LDL : Christie Ballantyne MD.: Discussion on barriers to reaching optimal LDL-C, HDL-C and triglycerides targets cardiovascular risk reduction.

Thu Aug 14

• The International Network of Cholesterol Skeptics

Wed Aug 13

• Lipoprotein Management in Patients With Cardiometaboli c Risk: Consensus Conference : ACC/ADA Report: Lipoprotein Management in Patients With Cardiometaboli c Risk: Consensus Conference Report From the American Diabetes Association (ADA) and the American College of Cardiology (ACC).
• ACC 2008: The Future of Managing Dyslipidemia: Phase II darapladib trial shows sustained, dose-dependent inhibition of plasma Lp-PLA2 activity in heart patients getting intensive atorvastatin therapy. Presented by Emile R. Mohler, III, MD, UPenn at ACC 2008.

Tue Aug 12

• Dyslipidemia in Women
• Antilipidemic Agents ... Pharmaceutical Drugs Chart ... Aetna

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Lipoproteins. If you would like to find related tags we recommend Tag Patterns > Lipoproteins

Off-site Lipoproteins Research Links

If you still need additional information on Lipoproteins then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.